DK0730861T3 - Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli - Google Patents

Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli

Info

Publication number
DK0730861T3
DK0730861T3 DK96102860T DK96102860T DK0730861T3 DK 0730861 T3 DK0730861 T3 DK 0730861T3 DK 96102860 T DK96102860 T DK 96102860T DK 96102860 T DK96102860 T DK 96102860T DK 0730861 T3 DK0730861 T3 DK 0730861T3
Authority
DK
Denmark
Prior art keywords
substituted
treatment
pharmaceutical compositions
compositions useful
aminotetralins
Prior art date
Application number
DK96102860T
Other languages
Danish (da)
English (en)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0730861T3 publication Critical patent/DK0730861T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK96102860T 1995-03-09 1996-02-26 Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli DK0730861T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000143A IT1278045B1 (it) 1995-03-09 1995-03-09 Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Publications (1)

Publication Number Publication Date
DK0730861T3 true DK0730861T3 (da) 2000-10-09

Family

ID=11403118

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96102860T DK0730861T3 (da) 1995-03-09 1996-02-26 Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli

Country Status (14)

Country Link
US (1) US5591777A (es)
EP (1) EP0730861B1 (es)
JP (1) JPH08268884A (es)
KR (1) KR100286141B1 (es)
AT (1) ATE195072T1 (es)
CA (1) CA2171081A1 (es)
DE (1) DE69609541T2 (es)
DK (1) DK0730861T3 (es)
ES (1) ES2150034T3 (es)
GR (1) GR3034688T3 (es)
IT (1) IT1278045B1 (es)
PT (1) PT730861E (es)
TW (1) TW471967B (es)
ZA (1) ZA961897B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290910B1 (it) * 1997-02-03 1998-12-14 Sigma Tau Ind Farmaceuti 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
IT1294932B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199339B (it) * 1986-12-23 1988-12-30 Sigma Tau Ind Farmaceuti N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono

Also Published As

Publication number Publication date
EP0730861B1 (en) 2000-08-02
IT1278045B1 (it) 1997-11-17
GR3034688T3 (en) 2001-01-31
DE69609541D1 (de) 2000-09-07
ITRM950143A1 (it) 1996-09-09
JPH08268884A (ja) 1996-10-15
ITRM950143A0 (it) 1995-03-09
TW471967B (en) 2002-01-11
US5591777A (en) 1997-01-07
ATE195072T1 (de) 2000-08-15
EP0730861A1 (en) 1996-09-11
CA2171081A1 (en) 1996-09-10
KR100286141B1 (ko) 2001-04-16
KR960033450A (ko) 1996-10-22
ZA961897B (en) 1996-09-12
DE69609541T2 (de) 2000-12-21
ES2150034T3 (es) 2000-11-16
PT730861E (pt) 2000-11-30

Similar Documents

Publication Publication Date Title
DK1002534T3 (da) Anvendelse af fire K-252a-derivater
NO911934L (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
NO913621D0 (no) Sementblanding og fremgangsmaate for fremstilling av blandingen.
FI940102A0 (fi) Foerfarande och anordning foer hoejande av en materialbanas glans och ytjaemnhet
ID24308A (id) Plasma darah yang dapat diaplikasikan secara universal
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
NO911122D0 (no) Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO870212D0 (no) Fremgangsmaate for fremstilling av stabile nikorandilpreparater.
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
NO910473L (no) Fremgangsmaate for fremstilling av tricykliske aminer.
NO902977L (no) Framgangsmaate for tilvirkning av keramer og keramiske komposittlegemer.
NO900643D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO902410D0 (no) Fremgangsmaate for rekondisjonering av stoeperisand.
DK627289D0 (da) Anvendelse af bicyclononanderivater
DK0730861T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
NO901321D0 (no) Fremgangsmaate for fremstilling av polycykliske aminer.
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
DK0635490T3 (da) Fremgangsmåde til fremstilling af N-ethylcarbazol
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
NO880405D0 (no) Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner.
FR2710673B1 (fr) Composition d'enduit de parement.
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose